Clinical Trials Browser

Phase 2/3 × Interventional × Deglutition Disorders × Clear all

NCT01786278 2013-02-07

BRASTEGAC

Phase 2/3 Unknown

Adenocarcinoma, Deglutition Disorders

NCT01279837 2012-01-05

Pharyngocise Dose Response Study

Phase 2/3 Completed

Deglutition Disorders, Head and Neck Neoplasms